Biodesix, Inc. (BDSX)
NASDAQ: BDSX · IEX Real-Time Price · USD
1.430
+0.080 (5.93%)
At close: May 31, 2024, 4:00 PM
1.350
-0.080 (-5.59%)
After-hours: May 31, 2024, 4:09 PM EDT

Biodesix Market Cap

Biodesix has a market cap or net worth of $164.00 million as of May 31, 2024. Its market cap has increased by 58.30% in one year.

Market Cap
164.00M
Enterprise Value
213.68M
1-Year Change
58.30%
Ranking
Category
Stock Price
$1.43

Market Cap Chart

Since the IPO on October 28, 2020, Biodesix's market cap has decreased from $472.57M to $164.00M, a decrease of -65.30%. That is a compound annual growth rate of -25.52%.

History

DateMarket Cap% Change
May 31, 2024164.00M5.94%
May 30, 2024154.80M-1.46%
May 29, 2024157.10M-5.53%
May 28, 2024166.30M-
May 24, 2024166.30M2.84%
May 23, 2024161.70M-7.23%
May 22, 2024174.30M-3.22%
May 21, 2024180.10M-
May 20, 2024180.10M-0.28%
May 17, 2024180.60M0.95%
May 16, 2024178.90M2.29%
May 15, 2024174.90M1.98%
May 14, 2024171.50M-1.61%
May 13, 2024174.30M-3.81%
May 10, 2024181.20M1.91%
May 9, 2024177.80M-
May 8, 2024177.80M18.30%
May 7, 2024150.30M1.97%
May 6, 2024147.40M8.62%
May 3, 2024135.70M6.85%
May 2, 2024127.00M4.79%
May 1, 2024121.20M0.83%
Apr 30, 2024120.20M1.61%
Apr 29, 2024118.30M-1.17%
Apr 26, 2024119.70M-1.97%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
X4 Pharmaceuticals 169.62M
Galectin Therapeutics 169.04M
Kodiak Sciences 167.06M
Outlook Therapeutics 165.48M
Adverum Biotechnologies 164.39M
Atossa Therapeutics 163.48M
Zomedica 163.36M
Rezolute 161.74M
Market Cap Rankings